Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences Subscribe to our YouTube channel for the latest MadeAi product updates

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

106 articles published Follow:
Rare Disease

Why Social Listening Matters in Rare Diseases

Understanding patient burden and unmet needs has always been essential in healthcare. But for rare diseases research, it is absolutely critical. When patient populations are small, heterogeneous, and often underserved, every insight carries weight. Yet traditional data sources—clinical trials, claims data, registries, and surveys—often fall short of capturing the lived reality of patients and caregivers…

Read More

Madeai webinar

2026 Predictions for AI in Life Sciences

Missed our live session? Get the recording now! On January 22, 2026, CapeStart and MadeAi hosted an exclusive webinar featuring industry innovators sharing key predictions for AI in Life Sciences in 2026. The session explores how organizations are moving beyond experimentation and preparing for AI integration across operational, regulatory, and scientific workflows. Insights were drawn…

Read More

FDA Literature Review

FDA Literature Review Requirements: Leveraging AI into Your Literature Review Strategy

Understanding FDA Literature Review Requirements The FDA requires literature reviews to ensure that regulatory decisions are based on solid scientific evidence. This isn't just about compiling papers; it's about systematically searching, appraising, and synthesizing published data to demonstrate safety, efficacy, and compliance. These requirements span multiple domains, from drug approvals to medical devices and health…

Read More